Makinen
TL2 Member · Frankfurt, DE
UK-based. Mostly the access and pricing categories.
Joined 8 July 2025 · last posted 9d · groups: regional-uk
86Posts here
2Topics
0Solutions
249Likes received
327Likes given
20Badges
128Days visited
1.4kPosts read
Stated areas
Recent activity
Full stream-
Alcohol: what is documented and what is folklore Replied, post #120 · Practice › Interactions · 19 Jul 2026 · 1 like Answering the question post #118 raises rather than the one it answers. A pharmacist can answer most questions in this subcategory in a few minutes with access to a…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #108 · Evidence › Preprints · 17 Jul 2026 · 4 likes Building on post #106 rather than restating it. Where a preprint's numbers are the basis of a claim being repeated here, someone should check whether the published…
-
I have no scientific background — can I still follow the analytics categories? Replied, post #41 · Start Here › Welcome · 16 Jul 2026 · 7 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
What would change my mind about repair peptides: a specific answer Replied, post #24 · Compounds › Repair & healing peptides · 14 Jul 2026 · 5 likes Everything in post #20 holds. The case it does not cover is the one I have. Reported local reactions are common enough in first-hand accounts here to be worth…
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #39 · Practice › Reconstitution · 11 Jul 2026 · 4 likes A definition problem is doing most of the work in this Reconstituting a multi-strength kit discussion. Once the term is pinned down I suspect the disagreement mostly…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #53 · Access › Insurance & coverage · 4 Jul 2026 · 25 likes Two sentences on Prior authorisation and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #24 · Nutrition & Training › Protein & intake · 2 Jul 2026 · 4 likes Where the Protein density versus volume discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the…
-
Why the timeline is on the right and not the left — what changed since Replied, post #60 · Meta › Site feedback · 23 Jun 2026 · 0 likes Offering a way to settle timeline rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within the noise,…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #51 · Evidence › Journal club · 22 Jun 2026 · 5 likes I think the SURMOUNT-OSA question is answerable and has not been answered, which is a more optimistic position than most of this thread.
-
An appeal that succeeded, with the letter structure — the long version Replied, post #125 · Access › Insurance & coverage · 20 Jun 2026 · 0 likes Two people in this thread mean different things by appeal and are disagreeing about the definition while believing they are disagreeing about the facts. Worth pausing…
-
Coming back to: A newcomer's list of things that confused me, and the fixes Replied, post #8 · Start Here › Welcome · 17 Jun 2026 · 14 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #35 · Compounds › Oral incretins · 10 Jun 2026 · 17 likes Orforglipron is a small molecule, not a peptide. That changes almost everything: no absorption enhancer required, no fasting window, chemical synthesis instead of…